Fosrenol (Lanthanum Carbonate)
SPD405-319
Phase 3 small_molecule completed
Quick answer
Fosrenol (Lanthanum Carbonate) for Chronic Kidney Disease, Stage 5 is a Phase 3 program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Chronic Kidney Disease, Stage 5
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed